Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Personal Products Industry Analysis

UpdatedJun 09, 2026
DataAggregated Company Financials
Companies109
  • 7D-0.3%
  • 3M-7.1%
  • 1Y-16.8%
  • YTD-12.4%

In the last week, Personal Products has been flat. Unfortunately though, the industry is down 17% over the past 12 months. As for the next few years, earnings are expected to grow by 34% per annum.

Industry Valuation and Performance

Has the U.S. Personal Products Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 09 Jun 2026US$79.2bUS$48.3bUS$699.1m17.5x113.3x1.6x
Thu, 07 May 2026US$80.1bUS$48.2bUS$638.5m20.5x125.4x1.7x
Sat, 04 Apr 2026US$73.9bUS$48.2bUS$638.8m21x115.6x1.5x
Mon, 02 Mar 2026US$95.1bUS$48.2bUS$839.5m21x113.2x2x
Wed, 28 Jan 2026US$95.9bUS$47.6bUS$350.0m22.8x273.9x2x
Fri, 26 Dec 2025US$90.9bUS$47.6bUS$351.3m22.3x258.8x1.9x
Sun, 23 Nov 2025US$82.5bUS$47.6bUS$517.3m22.2x159.6x1.7x
Tue, 21 Oct 2025US$90.6bUS$47.7bUS$307.8m20x294.2x1.9x
Thu, 18 Sep 2025US$94.6bUS$47.6bUS$303.9m21.3x311.3x2x
Sat, 16 Aug 2025US$99.7bUS$48.2bUS$536.2m20.7x185.9x2.1x
Mon, 14 Jul 2025US$101.1bUS$48.0bUS$109.5m17.6x923.1x2.1x
Wed, 11 Jun 2025US$93.7bUS$48.0bUS$127.2m17.3x736.5x2x
Fri, 09 May 2025US$89.4bUS$48.2b-US$32,397,463.1117.2x-2759.3x1.9x
Sun, 06 Apr 2025US$81.8bUS$48.7bUS$556.6m20.9x146.9x1.7x
Tue, 04 Mar 2025US$95.3bUS$49.0bUS$354.6m25.9x268.7x1.9x
Thu, 30 Jan 2025US$99.3bUS$49.3bUS$1.5b26.2x67.3x2x
Sat, 28 Dec 2024US$98.9bUS$49.3bUS$1.5b27.6x67x2x
Mon, 25 Nov 2024US$102.3bUS$49.3bUS$1.5b28.5x69.4x2.1x
Wed, 23 Oct 2024US$105.6bUS$49.5bUS$1.6b25.5x65.3x2.1x
Fri, 20 Sep 2024US$108.3bUS$49.5bUS$1.6b22.1x66.2x2.2x
Sun, 18 Aug 2024US$111.1bUS$49.2bUS$2.0b27.1x55.5x2.3x
Tue, 16 Jul 2024US$111.6bUS$49.0bUS$2.4b21.8x46.1x2.3x
Thu, 13 Jun 2024US$113.4bUS$49.0bUS$2.4b22.9x46.8x2.3x
Sat, 11 May 2024US$122.2bUS$48.8bUS$2.5b24.5x49.7x2.5x
Mon, 08 Apr 2024US$126.0bUS$48.8bUS$2.5b25.8x49.7x2.6x
Wed, 06 Mar 2024US$129.6bUS$49.0bUS$2.5b29.1x52.7x2.6x
Fri, 02 Feb 2024US$127.7bUS$50.1bUS$2.6b23.8x50x2.5x
Sun, 31 Dec 2023US$130.0bUS$49.9bUS$2.6b27.1x49.3x2.6x
Tue, 28 Nov 2023US$114.8bUS$49.9bUS$2.6b22.4x44.1x2.3x
Thu, 26 Oct 2023US$115.3bUS$50.0bUS$3.3b24x35.1x2.3x
Sat, 23 Sep 2023US$124.4bUS$50.0bUS$3.3b24.1x37.9x2.5x
Mon, 21 Aug 2023US$133.5bUS$49.8bUS$3.0b21.2x45.2x2.7x
Wed, 19 Jul 2023US$148.7bUS$49.2bUS$3.2b22.1x46.5x3x
Fri, 16 Jun 2023US$149.8bUS$49.3bUS$3.1b21.6x47.8x3x
Price to Earnings Ratio

47.8x


Total Market Cap: US$149.8bTotal Earnings: US$3.1bTotal Revenue: US$49.3bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Personal Products Industry Price to Earnings3Y Average 171.4x202420252026
Current Industry PE
  • Investors are pessimistic on the American Personal Products industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 113x which is lower than its 3-year average PE of 171x.
  • The 3-year average PS ratio of 2.2x is higher than the industry's current PS ratio of 1.6x.
Past Earnings Growth
  • The earnings for companies in the Personal Products industry have declined 39% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Consumer Staples industry?

US Market-2.73%
Consumer Staples1.99%
Personal Products-0.32%
Personal Products-0.32%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
KVUE KenvueUS$17.551.2%
+US$384.0m		-17.6%PE20.8x
EPC Edgewell Personal CareUS$20.2813.9%
+US$113.8m		-23.9%PS0.4x
LFVN LifeVantageUS$10.7013.5%
+US$16.0m		-14.3%PE23.5x
USNA USANA Health SciencesUS$18.702.0%
+US$6.8m		-37.3%PE38.9x
FTLF FitLife BrandsUS$10.374.6%
+US$4.3m		-26.9%PE16.2x

Latest News

KVUE
US$17.55
Kenvue
7D
1.2%
1Y
-17.6%
Seeking Alpha • 6h

Kenvue: After A Disappointing 3 Years, Kimberly-Clark's Gamble Could Revive Growth

Summary Kenvue Inc. faces near-term headwinds but offers long-term income potential, especially with its pending merger with Kimberly-Clark. Recent earnings showed resilience: Q1 revenue grew 4.5% to $3.91B and EPS rose to $0.32, despite macroeconomic pressures. The KVUE-KMB merger promises $2.1B in run-rate synergies, but meaningful growth is unlikely for 3–5 years amid inflation and regulatory scrutiny. With a forward P/E under 15x and a ~5% yield, KVUE stock is a solid hold; risks center on merger approval and ongoing margin pressures. Read the full article on Seeking Alpha
MTEX
US$5.63
Mannatech
7D
5.1%
1Y
-48.4%
LFVN
US$10.70
LifeVantage
7D
13.5%
1Y
-14.3%
Narrative Update • Jun 08

LFVN: Downgrade And Softer Guidance Will Limit Portugal Expansion Support

Analysts have reduced their fair value estimate for LifeVantage after a recent downgrade in Street research coverage, reflecting a slightly lower discount rate and modestly adjusted expectations for revenue trends, profit margins, and future P/E multiples. What's in the News LifeVantage updated guidance for the fiscal year ending June 30, 2026, and now expects revenue to be close to the lower end of its previously issued range.
ELF
US$52.28
e.l.f. Beauty
7D
-2.3%
1Y
-55.1%
EPC
US$20.28
Edgewell Personal Care
7D
13.9%
1Y
-23.9%
Narrative Update • Jun 06

EPC: Share Repurchases And Updated Outlook Will Drive Future Upside Potential

Analysts have nudged their price target on Edgewell Personal Care from about $24.17 to $24.50, reflecting updated assumptions around discount rates, revenue trends, profit margins and the stock's future P/E. What's in the News Edgewell Personal Care reported that from January 1, 2026 to March 31, 2026, it repurchased 224,000 shares, representing 0.48% of shares, for a total of US$15.01 million under its existing buyback program.
YSG
US$2.91
Yatsen Holding
7D
-16.1%
1Y
-58.9%
Narrative Update • Jun 04

YSG: Convertible Notes And Q2 2026 Guidance Will Drive Repricing

Analysts now place Yatsen Holding's fair value at $4.00, down from $5.80, reflecting updated assumptions for slightly lower revenue growth, a higher profit margin, a reduced future P/E multiple, and a small adjustment to the discount rate. What's in the News Yatsen issued revenue guidance for Q2 2026, expecting total net revenues between RMB1.20b and RMB1.30b.
BRBR
US$7.90
BellRing Brands
7D
-12.8%
1Y
-86.9%
Narrative Update • Jun 04

BRBR: Protein Adoption Trend Will Support Recovery After Recent Earnings Reset

Analysts have cut their price targets on BellRing Brands sharply, with one high profile reduction to $13 from $34 and a series of other target trims and downgrades following a disappointing quarter, rising concerns about competition, and ongoing estimate revisions. Analyst Commentary Recent Street research around BellRing Brands points to a clear reset in expectations, with multiple bearish analysts cutting price targets and, in some cases, downgrading ratings after the latest quarterly report.
WALD
US$1.64
Waldencast
7D
-10.4%
1Y
-29.3%
ODD
US$9.93
Oddity Tech
7D
-29.0%
1Y
-85.7%
Narrative Update • Jun 03

ODD: Ad Algorithm Reset And Buybacks Will Support Future Confidence Rebuild

Oddity Tech's analyst fair value estimate has shifted from $17.33 to $16.25 as analysts factor in lower Street price targets and concerns about higher customer acquisition costs and softer near term revenue trends, partly offset by signs of improving card data and resilient performance in other marketing channels. Analyst Commentary Recent Street research on Oddity Tech highlights a split view, with some focus on improving data points and others flagging execution and growth risks that feed into lower price targets and a more cautious stance.
HLF
US$11.34
Herbalife
7D
-4.7%
1Y
43.0%
Narrative Update • Jun 03

HLF: Refinancing And Margin Improvement Will Support Turnaround Despite Weak EBITDA Guidance

Narrative update on Herbalife Analysts have raised their price target on Herbalife by $2, citing research that points to updated assumptions around discount rates, revenue growth, profit margins, and future P/E expectations. Analyst Commentary Bullish analysts raising their price target by US$2 are signaling a more constructive view on how Herbalife’s valuation lines up with its fundamentals.
EL
US$84.64
Estée Lauder Companies
7D
-1.1%
1Y
22.7%
COTY
US$1.94
Coty
7D
-5.8%
1Y
-61.3%
Narrative Update • Jun 02

COTY: Prestige Margin Execution And New Launches Will Support Future Earnings Power

Analysts have nudged Coty's implied fair value slightly lower to about $6.70 per share, while adjusting P/E and margin assumptions and updating price targets with a series of recent $0.25 to $1.00 moves across the Street. Analyst Commentary Recent research has been mixed, with some firms trimming targets by US$0.50 to US$1.00 and others nudging them higher by US$0.25 to US$0.60.
USNA
US$18.70
USANA Health Sciences
7D
2.0%
1Y
-37.3%
Narrative Update • Jun 01

USNA: Skincare And Wellness Launches Will Support Future Upside Potential

Analysts have adjusted their price target for USANA Health Sciences to $39.00. Updated assumptions around discount rate, revenue growth, profit margin, and future P/E have shaped this new view on the stock.
FTLF
US$10.37
FitLife Brands
7D
4.6%
1Y
-26.9%